What is PAVmed Inc Annual Revenue?

PAVmed Inc Annual Revenue rose 61.85%, in the last year to $2.45 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

What is PAVmed Inc Annual Net Profit?

PAVmed Inc Annual Net Profit rose 9.1% in the last year to $64.18 M. Its sector's average net profit growth for the last fiscal year was 3.61%.

What is PAVmed Inc Price to Earning Ratio?

PAVmed Inc Price to Earning Ratio is 0.42, lower than its sector PE ratio of 31.37.

What is PAVmed Inc Stock Price?

PAVmed Inc Stock Price fell 63.41% and underperformed its sector by 71.07% in the past year.

What is PAVmed Inc Quarterly Revenue?

PAVmed Inc Quarterly Revenue rose 25.92% YoY to $1 M. Its sector's average revenue growth YoY for the quarter was 8.58%.

What is PAVmed Inc Quarterly Net profit?

PAVmed Inc Quarterly Net profit rose 464.43% YoY to $64.4 M. Its sector's average net profit growth YoY for the quarter was 27.3%.

What is PAVmed Inc Mutual Fund Holding?

PAVmed Inc Mutual Fund Holding decreased by 0.33% in the last quarter to 4.16.

What is PAVmed Inc Promoter Share Holding?

PAVmed Inc Promoter Share Holding stayed the same in the most recent quarter at 4.21%.

What is PAVmed Inc Interest Coverage Ratio?

PAVmed Inc Interest Coverage Ratio is -133.57, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is PAVmed Inc Institutional Holding?

PAVmed Inc Institutional Holding decreased by 2.5% in the last quarter to 9.25.

How is the PAVmed Inc today?

The PAVmed Inc today is trading in the down by -2.60% at 0.75.

How has PAVmed Inc performed historically?

The PAVmed Inc is currently trading down -2.60% on an intraday basis in the past week the index rose 19.05%. The index has been up 20.97% in the past quarter and fell -63.41% in the past year. You can view this in the overview section.

PAVmed Inc XNAS: PAVM

PAVmed Inc Live Share Price Today, Share Analysis and Chart

Name: PAVmed Inc: Is Infosys Ltd. worth buying?
Item: PAVmed Inc
Rating: 2.14358325
Author: Trendlyne DVM scores

Download real time

0.75 -0.02 (-2.60%)

73.59% Fall from 52W High

80,059 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

PAVmed Inc Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	10.2
PE TTM Below industry Median Unavailable in chosen country	0.4
Price to Book Negative Price to Book Unavailable in chosen country	-1.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	9.3
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	25.9
Operating Revenue growth TTM % High in industry Unavailable in chosen country	166.3
Net Profit Qtr Growth YoY % High in industry Unavailable in chosen country	464.4
Net Profit TTM Growth % High in industry Unavailable in chosen country	134.5
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-1,162.4
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-1,380.3
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	18
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-152.2

All financials are in USD Million and price data in USD

Not Eligible

Mid Valuation

40.3 / 100

Technically Neutral

45.4 / 100

1Yr Price target upside is 1100%

3 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Sell Zone

82.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

PAVmed Inc Stock Price Analysis

Day Price Range -2.6% 1 Day return Unavailable in chosen country	0.8 (LTP) 0.70.8 LowHigh
Week Price Range 19.0% 1 Week return Unavailable in chosen country	0.8 (LTP) 0.60.8 LowHigh
Month Price Range -10.7% 1 Month return Unavailable in chosen country	0.8 (LTP) 0.60.9 LowHigh
52 Week Price Range -63.4% 1 Year return Unavailable in chosen country	0.8 (LTP) 0.62.8 LowHigh

View full Share Price History

PAVmed Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

PAVmed Inc's Revenue was lower than average estimate 2 times in past 2 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-9.2

Avg. Estimate

2.5

Low Estimate

2.5

High Estimate

2.5

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 127.3% in FY24

Consensus Recommendation

3 ANALYST Recommendations

BUY

The consensus recommendation from 3 analysts for PAVmed Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

PAVmed Inc Stock Analysis

PAVmed Inc stock analysis with key metrics, changes, and trends.

PAVmed Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$2.45 M	61.85%	positive	Annual Revenue rose 61.85%, in the last year to $2.45 M. Its sector's average revenue growth for the last fiscal year was 8.73%.
Annual Net Profit	$64.18 M	9.1%	positive	Annual Net Profit rose 9.1% in the last year to $64.18 M. Its sector's average net profit growth for the last fiscal year was 3.61%.
Price to Earning Ratio	0.42	-	positive	Price to Earning Ratio is 0.42, lower than its sector PE ratio of 31.37.
Stock Price	$0.75	-63.41%	negative	Stock Price fell 63.41% and underperformed its sector by 71.07% in the past year.
Quarterly Revenue	$1 M	25.92%	positive	Quarterly Revenue rose 25.92% YoY to $1 M. Its sector's average revenue growth YoY for the quarter was 8.58%.
Quarterly Net profit	$64.4 M	464.43%	positive	Quarterly Net profit rose 464.43% YoY to $64.4 M. Its sector's average net profit growth YoY for the quarter was 27.3%.
Mutual Fund Holding	4.16 %	-0.33%	negative	Mutual Fund Holding decreased by 0.33% in the last quarter to 4.16.
Promoter Share Holding	4.21 %	0%	neutral	Promoter Share Holding stayed the same in the most recent quarter at 4.21%.
Interest Coverage Ratio	-133.57	-	negative	Interest Coverage Ratio is -133.57, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	9.25 %	-2.5%	negative	Institutional Holding decreased by 2.5% in the last quarter to 9.25.

VIEW LESS

Loading data..

PAVmed Inc - Company Profile

What does PAVmed Inc do?

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

2024

Gross Remuneration

Year

PAVmed Inc Live Share Price Today, Share Analysis and Chart

73.59% Fall from 52W High

PAVmed Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

RoA Annual %

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

PAVmed Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

PAVmed Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

PAVmed Inc's Revenue was lower than average estimate 2 times in past 2 years

EPS forecast

EPS is expected to grow by 127.3% in FY24

Consensus Recommendation

The consensus recommendation from 3 analysts for PAVmed Inc is BUY

PAVmed Inc Stock Analysis

PAVmed Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 61.85%, in the last year to $2.45 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit rose 9.1% in the last year to $64.18 M. Its sector's average net profit growth for the last fiscal year was 3.61%.

Price to Earning Ratio is 0.42, lower than its sector PE ratio of 31.37.

Stock Price fell 63.41% and underperformed its sector by 71.07% in the past year.

Quarterly Revenue rose 25.92% YoY to $1 M. Its sector's average revenue growth YoY for the quarter was 8.58%.

Quarterly Net profit rose 464.43% YoY to $64.4 M. Its sector's average net profit growth YoY for the quarter was 27.3%.

Mutual Fund Holding decreased by 0.33% in the last quarter to 4.16.

Promoter Share Holding stayed the same in the most recent quarter at 4.21%.

Interest Coverage Ratio is -133.57, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding decreased by 2.5% in the last quarter to 9.25.

PAVmed Inc - Company Profile

What does PAVmed Inc do?

PAVmed Inc Management structure

Dr. Lishan Aklog, M.D.

Chairman of the Board and Chief Executive Officer of the Company and Lucid

Mr. Michael Adam Gordon

General Counsel and Secretary

Mr. Dennis M. McGrath, C.P.A.

Chief Accounting Officer, President and Chief Financial Officer of the Company and Lucid

Mr. Shaun M. O'Neil

Executive Vice President and Chief Operating Officer

Dr. Brian J. DeGuzman

Chief Technology and Compliance Officer

PAVmed Inc Board of directors

Dr. James L. Cox, M.D.

Independent Director

Dr. Sundeep Agrawal, M.D.

Director

Ms. Joan B. Harvey

Independent Director

PAVmed Inc FAQ

How is PAVmed Inc today?

PAVmed Inc today is trading in the red, and is down by -2.60% at 0.75.